Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3354679
Max Phase: Preclinical
Molecular Formula: C27H41N9O5S
Molecular Weight: 603.75
Molecule Type: Protein
Associated Items:
ID: ALA3354679
Max Phase: Preclinical
Molecular Formula: C27H41N9O5S
Molecular Weight: 603.75
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nc2ccccc2s1
Standard InChI: InChI=1S/C27H41N9O5S/c1-14(2)13-16(28)24(40)35-19(10-11-21(29)37)25(41)33-15(3)23(39)34-18(8-6-12-32-27(30)31)22(38)26-36-17-7-4-5-9-20(17)42-26/h4-5,7,9,14-16,18-19H,6,8,10-13,28H2,1-3H3,(H2,29,37)(H,33,41)(H,34,39)(H,35,40)(H4,30,31,32)/t15-,16-,18-,19-/m0/s1
Standard InChI Key: CWONXXSKOMNCJK-CAMMJAKZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 603.75 | Molecular Weight (Monoisotopic): 603.2951 | AlogP: -0.14 | #Rotatable Bonds: 17 |
Polar Surface Area: 248.27 | Molecular Species: BASE | HBA: 9 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.72 | CX Basic pKa: 11.50 | CX LogP: -1.49 | CX LogD: -3.94 |
Aromatic Rings: 2 | Heavy Atoms: 42 | QED Weighted: 0.05 | Np Likeness Score: -0.31 |
1. Duchêne D, Colombo E, Désilets A, Boudreault PL, Leduc R, Marsault E, Najmanovich R.. (2014) Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2., 57 (23): [PMID:25387268] [10.1021/jm5015633] |
Source(1):